Profil

LABIED Soraya

Département de gynécologie-obstétrique > Centre de procréation médicalement assistée (CPMA)

See author's contact details
Main Referenced Co-authors
Nisolle, Michelle  (55)
Munaut, Carine  (50)
Henry, Laurie  (47)
Foidart, Jean-Michel  (45)
Noël, Agnès  (42)
Main Referenced Keywords
Fertility preservation (4); endometrium (3); fertility preservation (3); Z-VAD-FMK (3); endometriosis (2);
Main Referenced Unit & Research Centers
Giga-Cancer - ULiège [BE] (1)
Laboratoire de Biologie des Tumeurs et du Développement (1)
Main Referenced Disciplines
Reproductive medicine (gynecology, andrology, obstetrics) (56)
Anatomy (cytology, histology, embryology...) & physiology (4)
Engineering, computing & technology: Multidisciplinary, general & others (2)
Biochemistry, biophysics & molecular biology (1)

Publications (total 62)

The most downloaded
442 downloads
Henry, L., LABIED, S., Jouan, C., & Nisolle, M. (2021). Preservation of female fertility: The current therapeutic strategy. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. doi:10.1002/ijgo.13698 https://hdl.handle.net/2268/259568

The most cited

62 citations (Scopus®)

Labied, S., Delforge, Y., Munaut, C., Blacher, S., Colige, A., Delcombel, R., HENRY, L., Fransolet, M., JOUAN, C., Perrier d'Hauterive, S., Noël, A., Nisolle, M.* , & Foidart, J.-M.*. (2013). Isoform 111 of vascular endothelial growth factor (VEGF111) improves angiogenesis of ovarian tissue xenotransplantation. Transplantation, 95 (3), 426-433. doi:10.1097/TP.0b013e318279965c https://hdl.handle.net/2268/142566

LABIED, S., WENDERS, F., DESMECHT, A., GASPARD, O., RAVET, S., Nisolle, M., & Henry, L. (22 June 2023). Birth of twenty-seven healthy babies following transfer of fresh and frozen-thawed embryos derived from monopronuclear zygotes: a retrospective study [Poster presentation]. ESHRE 39th Annual Meeting, Copenhague, Denmark.
Peer reviewed

LABIED, S., DESMECHT, A., WENDERS, F., GASPARD, O., RAVET, S., Nisolle, M., & Henry, L. (20 April 2023). BIRTH OF TWENTY-SEVEN HEALTHY BABIES FOLLOWING TRANSFER OF FRESH AND FROZEN- THAWED EMBRYOS DERIVED FROM MONOPRONUCLEAR ZYGOTES: A RETROSPECTIVE STUDY [Poster presentation]. 10eme IVIRMA CONGRESS, Malaga, Spain.
Peer reviewed

Squatrito, M., Blacher, S., Henry, L., LABIED, S., Noël, A., Nisolle, M., & Munaut, C. (19 October 2022). Comparison of Morphological and Digital-Assisted Analysis for BCL6 Endometrial Expression in Women with Endometriosis. Journal of Clinical Medicine, 11 (20), 6164. doi:10.3390/jcm11206164
Peer Reviewed verified by ORBi

Henry, L., Vervier, J., BOUCHER, A., BRICHANT, G., GASPARD, O., LABIED, S., Munaut, C., RAVET, S., & Nisolle, M. (04 August 2022). Oocyte Cryopreservation in Patients with Endometriosis: Current Knowledge and Number Needed to Treat. Journal of Clinical Medicine, 11 (15), 4559. doi:10.3390/jcm11154559
Peer Reviewed verified by ORBi

Henry, L., LABIED, S., Jouan, C., & Nisolle, M. (2021). Preservation of female fertility: The current therapeutic strategy. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. doi:10.1002/ijgo.13698
Peer reviewed

Labied, S., Jouan, C., Wenders, F., Ravet, S., Gaspard, O., Thonon, F., Gridelet, V., Henry, L., PERRIER d'HAUTERIVE, S., & Nisolle, M. (2019). Comparison between paraffin and mineral oil covering on early human embryo culture: a prospective randomized study. Systems Biology in Reproductive Medicine, 1-6. doi:10.1080/19396368.2018.1492645
Peer Reviewed verified by ORBi

Fransolet, M., NOEL, L., HENRY, L., LABIED, S., Blacher, S., NISOLLE, M., & Munaut, C. (2019). Evaluation of Z-VAD-FMK as an anti-apoptotic drug to prevent granulosa cell apoptosis and follicular death after human ovarian tissue transplantation. Journal of Assisted Reproduction and Genetics. doi:10.1007/s10815-018-1353-8
Peer Reviewed verified by ORBi

Munaut, C., Fransolet, M., LABIED, S., & NISOLLE, M. (03 June 2016). Development and assessment of a new closed system for ovarian tissue vitrification [Paper presentation]. 12ième journées scientifiques du GRECOT, Paris, France.

Fransolet, M., NOEL, L., HENRY, L., LABIED, S., Noël, A., Nisolle, M., & Munaut, C. (25 January 2016). − Evaluation of Z-VAD-FMK as an anti-apoptotic drug to prevent granulosa cells apoptosis and follicle death after ovarian tissue transplantation [Poster presentation]. GIGA day.

HENRY, L., Fransolet, M., LABIED, S., Blacher, S., MASEREEL, M.-C., Foidart, J.-M., Noël, A., Nisolle, M., & Munaut, C. (2016). Supplementation of transport and freezing media with anti-apoptotic drugs improves ovarian cortex survival. Journal of Ovarian Research. doi:10.1186/s13048-016-0216-0
Peer Reviewed verified by ORBi

Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., NISOLLE, M., & Munaut, C. (14 June 2015). In vitro evaluation of an anti-apoptotic drug, Z-VAD-FMK, for further use in ovarian tissue transplantation [Poster presentation]. The 31th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE), Lisbonne, Portugal.

Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (13 May 2015). In vitro evaluation of Z-VAD-FMK, an anti-apoptotic drug, for further use in ovarian tissue transplantation [Poster presentation]. GIGA-Cancer day.

Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (11 February 2015). In vitro evaluation of Z-VAD-FMK, an anti-apoptotic drug, for further use in ovarian tissue transplantation [Poster presentation]. Séminaire des jeunes chercheurs Télévie.

Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (31 January 2015). Follicular maintenance after oavrian tissue transplantation with the anti-apoptotic drug Z-VAD-FMK [Poster presentation]. Meeting annuel de la Belgian Association for Cancer Research (BACR).

HENRY, L., Fransolet, M., LABIED, S., Masereel, M.-C., Blacher, S., Donneau, A.-F., Kirschvink, N., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (27 January 2015). Limitation of damage to ovarian cortex during cryopreservation by addition of anti-apoptotic drugs in transport and freezing media [Poster presentation]. GIGA day.

Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (27 January 2015). In vitro evaluation of Z-VAD-FMK, an anti-apoptotic drug, for further use in ovarian tissue transplantation [Poster presentation]. GIGA day.

Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut. (16 January 2015). In vitro evaluation of Z-VAD-FMK, an anti-apoptotic drug, for further use in ovarian tissue transplantation [Poster presentation]. International Society of Fertility Preservation (ISFP) meeting: “Freezing of oocytes, embryos and ovarian tissue: focus on fertility management and fertility preservation”.

Henry, L., LABIED, S., Fransolet, M., Kirschvink, N., Blacher, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (2015). Isoform 165 of vascular endothelial growth factor in collagen matrix improves ovine cryopreserved ovarian tissue revascularisation after xenotransplantation in mice. Reproductive Biology and Endocrinology, 13 (1), 15. doi:10.1186/s12958-015-0015-2
Peer Reviewed verified by ORBi

Munaut, C., Leenders, J., LABIED, S., Martin, M., Govaerts, B., De Tullio, P., & NISOLLE, M. (2015). Use of an endometriosis model in rats to reveal new non invasive biomarkers [Paper presentation]. 31ème meeting annuel de l’European Society of Human Reproduction & Embryology (ESHRE).

Fransolet, M., HENRY, L., LABIED, S., Noël, A., Nisolle, M., & Munaut, C. (2015). In vitro evaluation of the anti-apoptotic drug Z-VAD-FMK on human ovarian granulosa cell lines for further use in ovarian tissue transplantation. Journal of Assisted Reproduction and Genetics. doi:10.1007/s10815-015-0536-9
Peer Reviewed verified by ORBi

GASPARD, O., Danthine, D., RAVET, S., WENDERS, F., JOUAN, C., THONON, F., LABIED, S., GRIDELET, V., Dubois, M., PERRIER d'HAUTERIVE, S., & NISOLLE, M. (2015). Neonatal outcomes after IMSI and ICSI at the CPMA of the University of Liège [Poster presentation]. Congrès 2015 de la European Society for Human Reproduction and Embryology.

Fransolet, M., Henry, L., LABIED, S., Masereel, M.-C., Blacher, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (2015). Influence of mouse strain on ovarian tissue recovery after engraftment with angiogenic factor. Journal of Ovarian Research, 8 (1), 14. doi:10.1186/s13048-015-0142-6
Peer Reviewed verified by ORBi

HENRY, L., Fransolet, M., LABIED, S., MASEREEL, M.-C., Blacher, S., Donneau, A.-F., Kirschvink, N., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (14 November 2014). Use of anti-apoptotic drugs in transport and freezing media of cryopreserved sheep ovarian cortex to improve tissue survival [Poster presentation]. 32ème meeting scientifique de la Belgian Society of Reproductive Medicine (BSRM).

Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (14 November 2014). Potential effect of the anti-apoptotic drug Z-VAD-FMK on follicular maintenance in ovarian tissue cryopreservation [Poster presentation]. 32ème meeting scientifique de la Belgian Society of Reproductive Medicine (BSRM).

Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (30 September 2014). Does Z-VAD-FMK treatment could decrease follicular loss after autografting of cryopreserved ovarian tissue? [Poster presentation]. Mini-symposium annuel de l’EDT-Cancérologie Expérimentale.

Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (19 May 2014). Ovarian tissue recovery in SCID and NOD-SCID mice after VEGF111 or VEGF165 graft treatment [Poster presentation]. GIGA-Cancer day.

Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (15 May 2014). Impact of mice strains in ovarian tissue recovery after VEGF111 or VEGF165 graft treatment [Poster presentation]. BioLiège Bioforum 2014.

Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (01 February 2014). Impact of mice strains in ovarian tissue recovery after VEGF111 or VEGF165 graft treatment [Poster presentation]. Belgian Association for Cancer Research (BACR) annual meeting 2014.

Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (27 January 2014). Impact of mice strains in ovarian tissue recovery after VEGF111 or VEGF165 graft treatment [Poster presentation]. GIGA day.

GASPARD, O., RAVET, S., WENDERS, F., JOUAN, C., THONON, F., LABIED, S., GRIDELET, V., Hincourt, N., Lorquet, S., DECHENNE, V., GINER LLORET, C., Dubois, M., PERRIER d'HAUTERIVE, S., & NISOLLE, M. (2014). Five years of IMSI at CPMA-University of Liège [Poster presentation]. 32ème congrès de la Belgian Society of Reproductive Medicine.

Fransolet, M., Labied, S., Henry, L., Masereel, M.-C., Rozet, E., Kirschvink, N., Nisolle, M., & Munaut, C. (2014). Strategies for Using the Sheep Ovarian Cortex as a Model in Reproductive Medicine. PLoS ONE, 9 (3), 91073. doi:10.1371/journal.pone.0091073
Peer Reviewed verified by ORBi

Henry, L., Labied, S., Chiaradia, F., Munaut, C., & NISOLLE, M. (2014). Cancer et droit à la maternité. Revue Médicale de Liège, 69 (4), 188-193.
Peer reviewed

Fransolet, M., HENRY, L., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (05 December 2013). Z-VAD-FMK treatment prevents granulosa cells apoptosis induced by etoposide but not by hypoxia and serum starvation in vitro [Poster presentation]. Séminaire des chercheurs Télévie 2014.

Fransolet, M., HENRY, L., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (07 November 2013). Z-VAD-FMK treatment prevents granulosa cells apoptosis induced by etoposide but not by hypoxia and serum starvation in vitro [Poster presentation]. 3rd World Congress of the International Society for Fertility Preservation (ISFP).

HENRY, L., Fransolet, M., LABIED, S., Munaut, C., Kirschvink, N., Noël, A., Nisolle, M., & Foidart, J.-M. (17 May 2013). Effect of anti-apoptotic drugs to prevent follicles loss during ovarian cortex transport and cryopreservation [Poster presentation]. GIGA-Cancer day.

Fransolet, M., HENRY, L., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (17 May 2013). Do anti-apoptotic drugs prevent follicle loss after ovarian cortical graft to patient in remission? [Poster presentation]. GIGA-Cancer day.

HENRY, L., Fransolet, M., LABIED, S., Munaut, C., Kirschvink, N., Noël, A., Nisolle, M., & Foidart, J.-M. (21 March 2013). Do anti-apoptotic drugs prevent follicles loss during ovarian cortex transport and cryopreservation? [Poster presentation]. The International Congress on Oncological Perspectives of Fertility Preservation: Gynecological & Breast Cancer.

Fransolet, M., HENRY, L., Rozet, E., Blacher, S., Masereel, M.-C., Kirschvink, N., Foidart, J.-M., Noël, A., Nisolle, M., LABIED, S., & Munaut, C. (02 February 2013). How to use sheep ovarian tissue as a model to restore fertility in young women who received gonadotoxic treatment? [Poster presentation]. Belgian Association for Cancer Research (BACR) annual meeting.

Labied, S., Delforge, Y., Munaut, C., Blacher, S., Colige, A., Delcombel, R., HENRY, L., Fransolet, M., JOUAN, C., Perrier d'Hauterive, S., Noël, A., Nisolle, M.* , & Foidart, J.-M.*. (2013). Isoform 111 of vascular endothelial growth factor (VEGF111) improves angiogenesis of ovarian tissue xenotransplantation. Transplantation, 95 (3), 426-433. doi:10.1097/TP.0b013e318279965c
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Fransolet, M., HENRY, L., Rozet, E., Blacher, S., Masereel, M.-C., Kirschvink, N., Noël, A., Foidart, J.-M., NISOLLE, M., Labied, S., & Munaut, C. (10 December 2012). Use of Sheep Ovarian Tissue as a Model to Restore Fertility in Young Cancerous Women [Poster presentation]. Séminaire des chercheurs Télévie 2013.

HENRY, L., Delforge, Y., Blacher, S., Colige, A., Delcombel, R., Fransolet, M., JOUAN, C., PERRIER d'HAUTERIVE, S., Noël, A., Nisolle, M., Foidart, J.-M., Munaut, C., & LABIED, S. (10 December 2012). Isoform 111 of vascular endothelial growth factor (VEGF111) improves angiogenesis of ovarian tissue xenotransplantation [Poster presentation]. Televie's Researchers Seminar.

HENRY, L., Fransolet, M., LABIED, S., Blacher, S., Munaut, C., Colige, A., Kirschvink, N., Noël, A., Nisolle, M., & Foidart, J.-M. (30 November 2012). Does vascular endothelial growth factor improve ovarian tissue recovery after cryopreservation? [Poster presentation]. Belgian Society of Reproductive Medicine.

Fransolet, M., HENRY, L., Rozet, E., Blacher, S., Masereel, M.-C., Kirschvink, N., Foidart, J.-M., Noël, A., Nisolle, M., Munaut, C., & LABIED, S. (30 November 2012). Assessment of follicular density in sheep ovarian tissue and impact on experimental results [Poster presentation]. Belgian Society of Reproductive Medicine.

Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., PERRIER d'HAUTERIVE, S., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (22 June 2012). Influence of VEGF111 treatment on ovarian tissue xenografts in different mice strains [Poster presentation]. GIGA-Cancer day.

Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., PERRIER d'HAUTERIVE, S., Foidart, J.-M., Noël, A., Nisolle, M., Munaut, C., & LABIED, S. (04 May 2012). Comparison of different mice strains to test ovarian VEGF111 treated graft recovery [Poster presentation]. GIGA day.

Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., PERRIER d'HAUTERIVE, S., Foidart, J.-M., Noël, A., Munaut, C., LABIED, S., & Nisolle, M. (18 April 2012). Impact of mice strains in ovarian tissue recovery after VEGF111 graft treatment [Poster presentation]. Biomedica, The European Life Sciences Summit.

Henry, L., Fransolet, M., Labied, S., Blacher, S., Munaut, C., Colige, A., Kirschvink, N., Noël, A., Nisolle, M., & Foidart, J.-M. (2012). Does vascular endothelial growth factor improve ovarian tissue recovery after cryopreservation? In Giornale italiano di obstetricia e gynecologia (pp. 34(1):203).
Peer reviewed

Labied, S., Delforge, Y., Blacher, S., Munaut, C., Signolle, N., Colige, A., Janssen, L., HENRY, L., Perrier d'Hauterive, S., JOUAN, C., Kirschvink, N., Noël, A., Nisolle, M., & Foidart, J.-M. (2012). Isoform 111 of vascular endothelial growth factor (VEGF111) improves angiogenesis of ovarian tissue xenotransplantation. Journal of Assisted Reproduction and Genetics, 28 (11), 1009.
Peer Reviewed verified by ORBi

Labied, S., Blacher, S., Carmeliet, P., Noël, A., Frankenne, F., Foidart, J.-M., & Munaut, C. (2011). Transient reduction of placental angiogenesis in PAI-1 deficient mice. Physiological Genomics, 43 (4), 188-98. doi:10.1152/physiolgenomics.00147.2010
Peer Reviewed verified by ORBi

LABIED, S., Blacher, S., Carmeliet, P., Noël, A., Frankenne, F., Foidart, J.-M., & Munaut, C. (2011). Transient reduction of placental angiogenesis in PAI-1 deficient mice [Poster presentation]. Giga Day, Liège, Belgium.

HENRY, L., Fransolet, M., LABIED, S., Blacher, S., Munaut, C., Kirschvinck, N., Noël, A., NISOLLE, M., & Foidart, J.-M. (2011). Does isoforms 111 and 165 of vascular endothelial growth factor (VEGF111 and 165) improve transplanted ovarian tissue survival? Journal of Assisted Reproduction and Genetics, 28, 1009-1010.

LABIED, S., Delforge, Y., Blacher, S., Munaut, C., Signole, N., Colige, A., Janssen, L., HENRY, L., Fransolet, M., PERRIER d'HAUTERIVE, S., JOUAN, C., Kirschvink, N., Noël, A., NISOLLE, M., & Foidart, J.-M. (2011). Isoform 111 of vascular endothelial growth factor (VEGF111) improves angiogenesis of ovarian tissue xenotransplantation. Journal of Assisted Reproduction and Genetics, 28, 1099.

Henry, L., Fransolet, M., LABIED, S., Blacher, S., Munaut, C., Colige, A., Kirschvink, N., Noël, A., NISOLLE, M., & Foidart, J.-M. (2011). Does isoforms 111 and 165 of vascular endothelial growth factor (VEGF111 and 165) improve transplanted ovarian tissue survival? Journal of Assisted Reproduction and Genetics, 28, 1009-10.
Peer Reviewed verified by ORBi

LABIED, S., Blacher, S., Delforge, Y., Munaut, C., NISOLLE, M., & Foidart, J.-M. (27 May 2010). Vascular endothelial growth factor (VEGF) improves vessel density of transplanted sheep ovarian cortex [Poster presentation]. 1st International Congress on Controversies of Stem Cells, Reproductive Cells, Tissue and Organs (CRYO), Valence, Spain.

Labied, S., Galant, C., Nisolle, M., Ravet, S., Munaut, C., Marbaix, E., Foidart, J.-M., & Frankenne, F. (2009). Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time. Human Reproduction, 24 (1), 113-121. doi:10.1093/humrep/den339
Peer Reviewed verified by ORBi

Alvarez Gonzalez, M.-L., Galant, C., Frankenne, F., Nisolle, M., Labied, S., Foidart, J.-M., Marbaix, E., & Beliard, A. (2009). Development of an animal experimental model to study the effects of levonorgestrel on the human endometrium. Human Reproduction, 24 (3), 697-704. doi:10.1093/humrep/den437
Peer Reviewed verified by ORBi

Labied, S. (2008). Rôle des protéases et de leurs inhibiteurs dans la placentation et la vascularisation endométriale [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/315252

Ravet, S., Munaut, C., Blacher, S., Brichant, G., Labied, S., Beliard, A., Chabbert-Buffet, N., Bouchard, P., Foidart, J.-M., & Pintiaux, A. (2008). Persistence of an intact endometrial matrix and vessels structure in women exposed to VA-2914, a selective progesterone receptor modulator. Journal of Clinical Endocrinology and Metabolism, 93 (11), 4525-31. doi:10.1210/jc.2008-0731
Peer Reviewed verified by ORBi

Ravet, S., Labied, S., Blacher, S., Frankenne, F., Munaut, C., Fridman, V., Beliard, A., Foidart, J.-M., & Nisolle, M. (December 2007). Endometrial vessel maturation in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time. Human Reproduction, 22 (12), 3084-3091. doi:10.1093/humrep/dem238
Peer Reviewed verified by ORBi

Le Maire, S., Blacher, S., Labied, S., Frankenne, F., Foidart, J.-M., & Verly, J. (2005). Image analysis quantification of the angiogenesis on an embryonic implantation site [Paper presentation]. 9th European Congress for Stereology and Image Analysis and 7th International Conference on Stereology and Image Analysis in Materials Science STERMAT.

Le Maire, S., Blacher, S., Labied, S., Frankenne, F., Foidart, J.-M., & Verly, J. (2005). Caractérisation par analyse d’images de l’angiogenèse sur des coupes histologiques [Paper presentation]. 20ème Colloque sur le Traitement du Signal et des Images (GRETSI’O5), Louvain-La-Neuve, Belgium.

Oltenfreiter, R., Staelens, L., Labied, S., Kersemans, V., Frankenne, F., Noël, A., Van de Wiele, C., & Slegers, G. (2005). Tryptophane-based biphenylsulfonamide matrix metalloproteinase inhibitors as tumor imaging agents. Cancer Biotherapy and Radiopharmaceuticals, 20 (6), 639-47. doi:10.1089/cbr.2005.20.639
Peer Reviewed verified by ORBi

Contact ORBi